Tag: 2016

  • John Spellar – 2016 Parliamentary Question to the Ministry of Defence

    John Spellar – 2016 Parliamentary Question to the Ministry of Defence

    The below Parliamentary question was asked by John Spellar on 2016-10-10.

    To ask the Secretary of State for Defence, what proportion of people leaving the armed forces are still unemployed six months after the end of their service.

    Mark Lancaster

    UK Service personnel with four or more years’ Service who voluntarily left the Armed Forces in Financial Year 2014-15 (the latest statistic available) and used the Career Transition Partnership (CTP) services had the following estimated employment outcomes, up to six months after leaving:

    Service

    Employed %

    Economically Inactive %

    Unemployed %

    Royal Navy

    89% (1,950)

    7% (160)

    3% (70)

    Army

    84% (6,560)

    9% (690)

    7% (510)

    Royal Air Force

    83% (1,710)

    14% (290)

    4% (70)

    Total Average %

    85% (10,220)

    10% (1,150)

    6% (640)

    Notes: The Ministry of Defence (MOD) does not record the training outcomes of Service leavers. The following categories of personnel have been included in the definition of those leaving Service voluntarily; those reaching the end of their engagement; those giving notice to terminate and those medically discharged. Figures include all Service leavers who used the Career Transition Partnership, less Early Service Leavers (this includes those with less than four years’ service and those compulsorily discharged). The numbers and percentages for employment outcomes cannot be summed together, as the unemployment figures were calculated on a different population to the employment and economically inactive figures. All totals and sub-totals have been rounded and so may not equal the sums of their rounded parts. When rounding to the nearest 10, numbers ending in “5” have been rounded to the nearest multiple of 20 to prevent systematic bias.

    For Early Service Leavers (ESL i.e. those with less than four years service or those compulsorily discharged irrespective of length of Service), the Future Horizons Programme (FHP) for ESL was introduced on 1 October 2013. Between 1 October 2013 and 31 March 2014 approximately 33% of eligible personnel participated in FHP. During Financial Year 2014-15 some 62% of eligible personnel participated in the Future Horizons Programme. Prior to the establishment of FHP all ESL were entitled to unit level support as part of standard MOD policy.

    From 1 October 2015, the resettlement provision for ESL is termed CTP Future Horizons. Official statistics on the six-months post-discharge employment status of ESL who used CTP Future Horizons will be published in January 2017 as part of the CTP official statistic.

  • Luciana Berger – 2016 Parliamentary Question to the Department of Health

    Luciana Berger – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Luciana Berger on 2015-12-17.

    To ask the Secretary of State for Health, what steps he is taking to ensure that people with serious mental health issues are receiving appropriate physical health care.

    Alistair Burt

    We are committed to ensuring that the physical health of people with serious mental health issues is treated in the same way as the rest of the population.

    The delivery of physical checks and interventions to individuals with a serious mental health problem who are in NHS commissioned inpatient settings is now incentivised via a national Commissioning for Quality and Innovation indicator. Any needs identified by these health checks are met with the necessary interventions or referral to another clinician for assessment diagnosis and treatment.

    With other initiatives undertaken by NHS England and its partners, which include making information accessible to the public on the availability of health checks and supporting the development and rollout of tools and guidance to improve physical health assessment in primary care, we will continue to increase access to the same health initiatives that benefit the general population. This will support improved health outcomes and reductions in unnecessary emergency and unplanned physical care for people with a serious mental health issue.

  • Tim Loughton – 2016 Parliamentary Question to the HM Treasury

    Tim Loughton – 2016 Parliamentary Question to the HM Treasury

    The below Parliamentary question was asked by Tim Loughton on 2016-01-27.

    To ask Mr Chancellor of the Exchequer, when he plans to reply to the letter from the hon. Members for East Worthing and Shoreham and Kingston upon Hull West and Hessle on the British Mercantile Marine Memorial Collection which was sent on 28 October 2015 and resent on 5 January 2016.

    Greg Hands

    I replied to the Hon. Member on 19 November 2015. A copy of my reply has been resent.

  • Steve Reed – 2016 Parliamentary Question to the Department for Communities and Local Government

    Steve Reed – 2016 Parliamentary Question to the Department for Communities and Local Government

    The below Parliamentary question was asked by Steve Reed on 2016-02-19.

    To ask the Secretary of State for Communities and Local Government, how many official visits he has made to local authorities since May 2015 where the primary purpose of the visit was in connection with the Northern Powerhouse policy.

    Greg Clark

    As part of my Ministerial duties I visit local authorities across the country, including regular visits in connection with the Northern Powerhouse.

  • Barry Gardiner – 2016 Parliamentary Question to the Cabinet Office

    Barry Gardiner – 2016 Parliamentary Question to the Cabinet Office

    The below Parliamentary question was asked by Barry Gardiner on 2016-03-15.

    To ask the Minister for the Cabinet Office, what recent discussions he has had with representatives of science and research and charity organisations on the potential effect of including anti-lobbying clauses in grant agreements.

    Matthew Hancock

    The new clause in government grants makes sure that taxpayers’ money is not diverted from their intended purpose and wasted on political campaigning and political lobbying.

    As indicated at the House of Lords Science Technology Committee, BIS and Cabinet Office are looking into how this new clause will apply to academic research.

  • Lord Myners – 2016 Parliamentary Question to the HM Treasury

    Lord Myners – 2016 Parliamentary Question to the HM Treasury

    The below Parliamentary question was asked by Lord Myners on 2016-04-19.

    To ask Her Majesty’s Government what steps they will take to ensure that the liquidity ladder is not used to advantage counterparties of Euronext to the disadvantage of those of LCH Clearnet.

    Lord O’Neill of Gatley

    I refer the noble Lord to my written answers of 26 April (HL7583, HL7584, HL7585, and HL7586)

  • Nicholas Brown – 2016 Parliamentary Question to the Department of Health

    Nicholas Brown – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Nicholas Brown on 2016-05-26.

    To ask the Secretary of State for Health, what information his Department holds on the use of peptide receptor radionuclide therapy treatments to target carcinoid tumours.

    George Freeman

    Information on the peptide receptor radionuclide therapy treatments funded through the Cancer Drugs Fund (CDF) is shown in the table. It is not known for what type of cancer these treatments have been provided.

    Number of patients treated in 2011/121

    Number of patients treated in 2012/131

    Number of CDF notifications 2013/142

    Number of CDF notifications 2014/152

    Number of CDF notifications 2015/16 (to Sept) 2

    Peptide receptor radionuclide therapy (to include Lutetium-177 or Yttrium-90 octreotide analogues)

    49

    117

    152

    229

    116

    1 Source: Strategic Health Authority returns to the Department of Health

    2 Source: NHS England

    Information on the number of peptide receptor radionuclide therapy treatments provided outside of the CDF is not collected.

  • Craig Whittaker – 2016 Parliamentary Question to the Foreign and Commonwealth Office

    Craig Whittaker – 2016 Parliamentary Question to the Foreign and Commonwealth Office

    The below Parliamentary question was asked by Craig Whittaker on 2016-07-18.

    To ask the Secretary of State for Foreign and Commonwealth Affairs, if his Department will work with (a) Oman and (b) other Middle Eastern countries to broker a deal to end the current conflict in Yemen.

    Mr Tobias Ellwood

    The Foreign Secretary, my Rt Hon. Friend the Member for Uxbridge and South Ruislip (Mr Johnson), met his Saudi, Emirates and US counterparts on 19 July in London to review the situation in Yemen. A political solution is the best way to bring long-term stability and end the conflict. We welcome and fully support the UN led talks in Kuwait: now is the time to reach an agreement. We will continue to work closely with the UN and partners in the Middle East, including Oman, to encourage both sides to engage constructively.

  • Justin Madders – 2016 Parliamentary Question to the Department of Health

    Justin Madders – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Justin Madders on 2016-10-10.

    To ask the Secretary of State for Health, what assessment he has made of the likely effect of proposed changes to pharmacy funding on home delivery of NHS prescriptions.

    David Mowat

    The Government’s proposals for community pharmacy in 2016/17 and beyond, on which we have consulted, are being considered against the public sector equality duty, the family test and the relevant duties of my Rt. hon. Friend, the Secretary of State for Health, under the National Health Service Act 2006.

    Our assessments include consideration of the potential impacts on the adequate provision of NHS pharmaceutical services, including the supply of medicines, access to NHS pharmaceutical services, supplementary hours, non-commissioned services, individuals with protected characteristics, impacts on other NHS services, health inequalities, individuals with restricted mobility and access to healthcare for deprived communities.

    An impact assessment will be completed to inform final decisions and published in due course.

    Our proposals are about improving services for patients and the public and securing efficiencies and savings. We believe these efficiencies can be made within community pharmacy without compromising the quality of services or public access to them.

    Our aim is to ensure that those community pharmacies upon which people depend continue to thrive. We are consulting on the introduction of a Pharmacy Access Scheme, which will provide more NHS funds to certain pharmacies compared with others, considering factors such as location and the health needs of the local population.

    We want a clinically focussed community pharmacy service that is better integrated with primary care and public health in line with the Five Year Forward View. This will help relieve the pressure on general practitioners and accident and emergency departments, ensure better use of medicines and better patient outcomes, and contribute to delivering seven day health and care services.

    The Chief Pharmaceutical Officer for England, Dr Keith Ridge has commissioned an independent review of community pharmacy clinical services. The review is being led by Richard Murray, Director of Policy at The King’s Fund. The final recommendations will be considered as part of the development of clinical and cost effective patient care by pharmacists and their teams.

    NHS England is also setting up a Pharmacy Integration Fund to support the development of clinical pharmacy practice in a wider range of primary care settings, resulting in a more integrated and effective NHS primary care patient pathway.

    The rollout of the additional 1,500 clinical pharmacists announced by NHS England will help to ease current pressures in general practice by working with patients who have long term conditions and others with multiple medications. Having a pharmacist on site will mean that patients who receive care from their general practice will be able to benefit from the expertise in medicines that these pharmacists provide.

  • Andy Slaughter – 2016 Parliamentary Question to the Ministry of Justice

    Andy Slaughter – 2016 Parliamentary Question to the Ministry of Justice

    The below Parliamentary question was asked by Andy Slaughter on 2015-12-17.

    To ask the Secretary of State for Justice, how many magistrates’ courts opened in each local justice area in each year since 2010.

    Mr Shailesh Vara

    The tables below show magistrates’ courts that have opened since 2010. Each of these new courts replaced multiple smaller facilities, providing modern and efficient premises in place of buildings which were unfit for purpose.

    2011

    Westminster Magistrates Court

    2012

    Aberystwyth Justice Centre

    Chelmsford Magistrates Court

    Colchester Magistrates Court

    Newport Magistrates Court

    It is not possible to present the above sites by their local justice areas as many local justice area boundaries change over time.